174 related articles for article (PubMed ID: 35184331)
21. Immunoglobulin heavy and light chain isotypes in multiple myeloma patients.
Ansari NA; Owais M; Usha
Asian Pac J Cancer Prev; 2007; 8(4):593-6. PubMed ID: 18260735
[TBL] [Abstract][Full Text] [Related]
22. [Monoclonal IgA serum protein having a poor precipitation reaction to anti-lambda chain antiserum in the patient with multiple myeloma].
Sato K; Michibayashi T
Rinsho Byori; 1985 Dec; 33(12):1425-9. PubMed ID: 3938490
[No Abstract] [Full Text] [Related]
23. Relationship of differences in immunoglobulin heavy/light chain pairs (Hevylite), selected laboratory parameters and stratification systems in different immunochemical types of multiple myeloma.
Scudla V; Lochman P; Pika T; Minarik J; Zapletalova J; Bacovsky J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Mar; 160(1):84-93. PubMed ID: 26365929
[TBL] [Abstract][Full Text] [Related]
24. Correlations among different markers determined by immunochemical methods used for the diagnosis and monitoring of intact immunoglobulin multiple myeloma cases.
Dogaru M; Lazăr V; Coriu D
Roum Arch Microbiol Immunol; 2012; 71(4):183-200. PubMed ID: 23755700
[TBL] [Abstract][Full Text] [Related]
25. Investigation of saliva immunoglobulins in monoclonal gammopathies.
Lajos J; Komán A; Boromissza E; Rojti M
Ann Immunol Hung; 1975; 18():99-104. PubMed ID: 1235961
[TBL] [Abstract][Full Text] [Related]
26. Saliva immunoglobulin free light chain analysis for monitoring disease activity and response to treatment in multiple sclerosis.
Lotan I; Ganelin-Cohen E; Tartakovsky E; Khasminsky V; Hellmann MA; Steiner I; Ben-Zvi I; Livneh A; Golderman S; Kaplan B
Mult Scler Relat Disord; 2020 Sep; 44():102339. PubMed ID: 32599469
[TBL] [Abstract][Full Text] [Related]
27. Monitoring IgA multiple myeloma: immunoglobulin heavy/light chain assays.
Katzmann JA; Willrich MA; Kohlhagen MC; Kyle RA; Murray DL; Snyder MR; Rajkumar SV; Dispenzieri A
Clin Chem; 2015 Feb; 61(2):360-7. PubMed ID: 25451866
[TBL] [Abstract][Full Text] [Related]
28. Levels of uninvolved immunoglobulins predict clinical status and progression-free survival for multiple myeloma patients.
Harutyunyan NM; Vardanyan S; Ghermezi M; Gottlieb J; Berenson A; Andreu-Vieyra C; Berenson JR
Br J Haematol; 2016 Jul; 174(1):81-7. PubMed ID: 27017948
[TBL] [Abstract][Full Text] [Related]
29. Role of different hematologic variables in defining the risk of malignant transformation in monoclonal gammopathy.
Baldini L; Guffanti A; Cesana BM; Colombi M; Chiorboli O; Damilano I; Maiolo AT
Blood; 1996 Feb; 87(3):912-8. PubMed ID: 8562962
[TBL] [Abstract][Full Text] [Related]
30. Application of Capillary Electrophoresis in Monoclonal Gammopathies and the Cutoff Value of Monoclonal Protein in Differential Diagnosis of Multiple Myeloma and Other Monoclonal Gammopathies.
Cao F; Zhang R; Xu L; Liu M; Yuan Y
Ann Clin Lab Sci; 2021 May; 51(3):400-407. PubMed ID: 34162571
[TBL] [Abstract][Full Text] [Related]
31. Intensified training increases salivary free light chains in trained cyclists: Indication that training volume increases oral inflammation.
Heaney JLJ; Killer SC; Svendsen IS; Gleeson M; Campbell JP
Physiol Behav; 2018 May; 188():181-187. PubMed ID: 29427565
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic performance of routine electrophoresis and immunofixation for the detection of immunoglobulin paraproteins (M-Proteins) in dogs with multiple myeloma and related disorders: Part 2-Toward improved diagnostic performance.
Moore AR; Harris RA; Jeffries C; Ashton L; Avery PR
Vet Clin Pathol; 2021 Jun; 50(2):249-258. PubMed ID: 33855710
[TBL] [Abstract][Full Text] [Related]
33. Cytoplasmic immunoglobulins in bone marrow cells of polyclonal and of monoclonal origin.
Morell A; Skvaril F; Huser HJ; Spengler G; Barandun S
Acta Haematol; 1978; 60(3):137-47. PubMed ID: 101001
[TBL] [Abstract][Full Text] [Related]
34. [Isotypic characterization of IgA paraproteins: association with other clinical and analytic data].
González González JB; García Delgado R; Cámara Sáez E; Ortiz Maslloréns F
Rev Clin Esp; 1996 Aug; 196(8):529-35. PubMed ID: 8984539
[TBL] [Abstract][Full Text] [Related]
35. Immunoglobulin class switch from IgG to IgA in a patient with smoldering multiple myeloma.
Takahashi M; Tsukada T; Kojima M; Koide T; Koike T; Takahashi H; Sakai C; Kashimura M; Shibata A
Blood; 1986 Jun; 67(6):1710-3. PubMed ID: 3085748
[TBL] [Abstract][Full Text] [Related]
36. IgG heavy-chain subclass typing of myeloma paraproteins by isoelectric focusing immunoblot analysis.
Fasullo FJ; Fritsche HA; Liu FJ; Hamilton RG
Clin Chem; 1989 Mar; 35(3):364-8. PubMed ID: 2493340
[TBL] [Abstract][Full Text] [Related]
37. Individual serum proteins and acute phase reactants in monoclonal immunoglobulinopathies (a study in patients with IgA myeloma and light chain myeloma).
Wiedermann D; Widermann B; Cídl K; Scudla V
Neoplasma; 1979; 26(3):315-24. PubMed ID: 119165
[No Abstract] [Full Text] [Related]
38. [A case of multiple myeloma with double M-protein peaks for IgG-kappa and IgA-kappa].
Tadao F; Hayashi M; Ichikawa K; Hirasawa Y; Ohtani H; Saito M; Hatimura K; Oshikawa T; Takayama M; Mori N
Rinsho Ketsueki; 1984 Oct; 25(10):1646-52. PubMed ID: 6441031
[No Abstract] [Full Text] [Related]
39. Salivary free light chains as a new biomarker to measure psychological stress: the impact of a university exam period on salivary immunoglobulins, cortisol, DHEA and symptoms of infection.
Irshad L; Faustini S; Evans L; Drayson MT; Campbell JP; Heaney JLJ
Psychoneuroendocrinology; 2020 Dec; 122():104912. PubMed ID: 33086142
[TBL] [Abstract][Full Text] [Related]
40. IgA kappa/IgA lambda heavy/light chain assessment in the management of patients with IgA myeloma.
Boyle EM; Fouquet G; Guidez S; Bonnet S; Demarquette H; Dulery R; Herbaux C; Noel MP; Manier S; Schraen S; Onraed B; Faucompré JL; Hennache B; Petillon MO; Mathiot C; Avet-Loiseau H; Facon T; Harding SJ; Moreau P; Leleu X
Cancer; 2014 Dec; 120(24):3952-7. PubMed ID: 25116271
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
